Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase

References

• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
   PubMed Web of Science ®Google Scholar
• Chen YF, Chang ET, Liu ZW, et al. Residence characteristics and risk of nasopharyngeal carcinoma in southern China: a population-based case-control study. Environ Int. 2021;151:106455.
   PubMed Web of Science ®Google Scholar
• Zhang ZN, Zhang YL, Qiu YL, et al. Human/eukaryotic ribosomal protein L14 (RPL14/eL14) overexpression represses proliferation, migration, invasion and EMT process in nasopharyngeal carcinoma. Bioengineered. 2021;12(1):2175–2186.
   PubMed Web of Science ®Google Scholar
• Peng L, Liu JQ, Xu C, et al. The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma. Radiat Oncol. 2019;14(1):9.
   PubMedGoogle Scholar
• Tsao SW, Tsang CM, Lo KW. Epstein–Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):28893937.
   Web of Science ®Google Scholar
• KCA C, JKS W, King A, et al. Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377(6):513–522.
   PubMed Web of Science ®Google Scholar
• Lam WKJ, Jiang P, Chan KCA, et al. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma. Proc Natl Acad Sci U S A. 2018;115(22):E5115–E5124.
   PubMed Web of Science ®Google Scholar
• Tan LP, Tan GW, Sivanesan VM, et al. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma. Int J Cancer. 2020;146(8):2336–2347.
   PubMed Web of Science ®Google Scholar
• Han B, Yang X, Zhang P, et al. DNA methylation biomarkers for nasopharyngeal carcinoma. PLOS ONE. 2020;15(4):e0230524.
   PubMed Web of Science ®Google Scholar
• Zou X, Zhu D, Zhang H, et al. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis. Gene. 2020;727:144243.
   PubMed Web of Science ®Google Scholar
• Zhang JZ, Wu ZH, Cheng Q. Screening and identification of key biomarkers in nasopharyngeal carcinoma: evidence from bioinformatic analysis. Med (Baltim). 2019;98(48):e17997.
   PubMed Web of Science ®Google Scholar
• Wei JZ, Ye JX, Luo Y, et al. EB virus promotes metastatic potential by boosting STIM1-dependent Ca2+ signaling in nasopharyngeal carcinoma cells. Cancer Lett. 2020;478:122–132.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Anderson DM, Anderson KM, Chang CL, et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015;160(4):595–606.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Xu H, Wang CH, et al. Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(6):3077–3084.
   PubMed Web of Science ®Google Scholar
• Xue MY, Cao HX. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p. Eur Rev Med Pharmacol Sci. 2020;24(7):3724–3733.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang F. Novel long noncoding RNA LINC01385 promotes nasopharyngeal carcinoma proliferation via the miR-140-3p/Twist1 signaling pathway. Cell Cycle. 2020;19(11):1352–1362.
   PubMed Web of Science ®Google Scholar
• Liao B, Yi Y, Zeng L, et al. LINC00667 sponges miR-4319 to promote the development of nasopharyngeal carcinoma by increasing FOXQ1 expression. Front Oncol. 2020;10:632813.
   PubMed Web of Science ®Google Scholar
• Yao H, Yang L, Tian L, et al. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2). Cancer Cell Int. 2020;20:138.
   PubMed Web of Science ®Google Scholar
• Jiao W, Liu F, Tang FZ, et al. Expression of the Pokemon proto-oncogene in nasopharyngeal carcinoma cell lines and tissues. Asian Pac J Cancer Prev. 2013;14(11):6315–6319.
   PubMedGoogle Scholar
• Liu F, Lan J, Jiao W, et al. Differences in Zbtb7a expression cause heterogeneous changes in human nasopharyngeal carcinoma CNE3 sublines. Oncol Lett. 2017;14(3):2669–2676.
   PubMed Web of Science ®Google Scholar
• Liu F, Tang F, Lan J, et al. Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma. Tumori. 2018;104(1):37–42.
   PubMed Web of Science ®Google Scholar
• Liu F, Wei JZ, Hao YR, et al. Long noncoding RNAs and messenger RNAs expression profiles potentially regulated by ZBTB7A in nasopharyngeal carcinoma. BioMed Res Int. 2019;2019:7246491.
   PubMed Web of Science ®Google Scholar
• Guo D, Bell EH, Mischel P, et al. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014;20(15):2619–2626.
   PubMed Web of Science ®Google Scholar
• Zou ZW, Ma C, Medoro L, et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016;7(38):61741–61754.
   PubMedGoogle Scholar
• ÁL R-C, Riquelme I, Brebi-Mieville P. Tools for sequence-based miRNA target prediction: what to choose?. Int J Mol Sci. 2016;17(12):1987.
   PubMed Web of Science ®Google Scholar
• Pan XF, Peng G, Liu S, et al. MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells. Int J Mol Med. 2015;36(2):559–564.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Pan J, Zhao LX. Long non-coding RNA histone deacetylase 4 antisense RNA 1 (HDAC4-AS1) inhibits HDAC4 expression in human ARPE-19 cells with hypoxic stress. Bioengineered. 2021;12(1):2228–2237.
   PubMed Web of Science ®Google Scholar
• Hou J, Yan J, Ren XY, et al. Long noncoding RNA ROR1-AS1 induces tumor metastasis and epithelial-mesenchymal transition by sponging miR-375 in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(1):174–180.
   PubMed Web of Science ®Google Scholar
• Hu W, Li H, LncRNA WS. SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis. BMC Cancer. 2020;20(1):376.
   PubMed Web of Science ®Google Scholar
• Chen X, Huang Y, Shi D, et al. LncRNA ZNF667-AS1 promotes ABLIM1 expression by adsorbing microRNA-1290 to suppress nasopharyngeal carcinoma cell progression. Onco Targets Ther. 2020;13:4397–4409.
   PubMed Web of Science ®Google Scholar
• Chen L, Sun L, Dong L, et al. The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism. Onco Targets Ther. 2017;10:2769–2778.
   PubMed Web of Science ®Google Scholar
• Lo AK, Lung RW, Dawson CW, et al. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein–Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. J Pathol. 2018;246(2):180–190.
   PubMed Web of Science ®Google Scholar
• Song LB, Wang HM, Zeng MS, et al. Study on the tumor heterogeneity of nasopharyngeal carcinoma cell line (SUNE-1). Ai Zheng. 1998;17(5):324–327. in Chinese.
   Google Scholar